Author: Christoph Breitenstroter
-
Biologicals at the Tipping Point: Driving Adoption Through Integration, Trust and Collaboration : A Conversation with Christoph Breitenstroter
Beyond Products: Bayer’s Strategy for Scaling Biologicals Through Integrated Systems An Interview with Christoph Breitenströter, Head of Biologicals EMEA at Bayer Christoph Breitenströter serves as the Head of Biologicals EMEA at Bayer, where he leads the strategic direction and commercial execution for the company’s biological portfolio. With an 18-year tenure at Bayer, Breitenströter emphasizes that…